The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
An Improved Plasmid DNA Expression Vector for Direct Injection into Skeletal Muscle
Abstract
In previous work, the direct injection of 50 μg of a plasmid DNA vector encoding firefly luciferase (VR1205) into murine quadriceps muscle produced an average of 6.5 ng of luciferase per muscle at 7 days postinjection. In this report, various elements of the VR1205 vector were modified to increase gene expression levels or to eliminate undesired viral sequences. Expression of the modified vectors was then compared to VR1205 using the intramuscular injection assay. In general, modifications to promoter, enhancer, and intronic sequences either decreased luciferase expression levels or had no effect. However, modifications to the polyadenylation and transcriptional termination sequences, plasmid backbone elements, and the luciferase gene itself each increased luciferase expression levels. The best-expressing vector, designated VR1255, contained a combination of these incrementally beneficial changes. A single intramuscular injection of 50 μg of VR1255 produced 300 ng of luciferase at 7 days postinjection, an expression level 46-fold higher than the VR1205 vector (or 22-fold higher, excluding modifications to the luciferase gene) and 154-fold higher than a commercially available luciferase expression vector. Thus, VR1255 represents an improved plasmid DNA vector that may be useful for gene therapy applications. The direct injection of plasmid DNA into mouse skeletal muscle was used as an in vivo assay platform to evaluate vector design improvements. Preexisting plasmid DNA vectors were systematically altered and tested, resulting in the production of a new gene therapy vector that can express up to 1 μg of transgene product after a single injection into muscle. The new vector, termed VR1255, represents a significant improvement over previously generated plasmid DNA expression vectors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Firefly luciferase gene: structure and expression in mammalian cells.
de Wet, J. R., Wood, K. V., DeLuca, M., Helinski, D. R., & Subramani, S. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.725 · Cited by 3,087
Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein
Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V. J., Gromkowski, S. H., Deck, R. R., DeWitt, C. M., Friedman, A., et al. (1993) · Science · doi:10.1126/science.8456302 · Cited by 2,318
Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gönczöl, E., & Wilson, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4407 · Cited by 1,575
A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus
BOSHART, M., WEBER, F., JAHN, G., DORSCHHLER, K., FLECKENSTEIN, B., & SCHAFFNER, W. (1985) · Cell · doi:10.1016/s0092-8674(85)80025-8 · Cited by 1,140
A conserved tripeptide sorts proteins to peroxisomes.
Gould, S. J., Keller, G. A., Hosken, N., Wilkinson, J., & Subramani, S. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.5.1657 · Cited by 1,106
Complete nucleotide sequence of SV40 DNA
Fiers, W., Contreras, R., Haegeman, G., Rogiers, R., Van de Voorde, A., Van Heuverswyn, H., Van Herreweghe, J., Volckaert, G., & Ysebaert, M. (1978) · Nature · doi:10.1038/273113a0 · Cited by 1,010
Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs
Acsadi, G., Dickson, G., Love, D. R., Jani, A., Walsh, F. S., Gurusinghe, A., Wolff, J. A., & Davies, K. E. (1991) · Nature · doi:10.1038/352815a0 · Cited by 485
Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein.
Sedegah, M., Hedstrom, R., Hobart, P., & Hoffman, S. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9866 · Cited by 447
Self-citationManthorpe, M., Cornefert-Jensen, F., Hartikka, J., Felgner, J., Rundell, A., Margalith, M., & Dwarki, V. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.4-419 · Cited by 432
Self-citationA generic intron increases gene expression in transgenic mice.
Choi, T., Huang, M., Gorman, C., & Jaenisch, R. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.6.3070 · Cited by 356
Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA
Cox, G. J., Zamb, T. J., & Babiuk, L. A. (1993) · Journal of Virology · doi:10.1128/jvi.67.9.5664-5667.1993 · Cited by 342
Promoters responsive to DNA bending: a common theme in prokaryotic gene expression
Pérez‐Martín, J., Rojo, F., & de Lorenzo, V. (1994) · Microbiological Reviews · doi:10.1128/mmbr.58.2.268-290.1994 · Cited by 336
Plasmid DNA Is Superior to Viral Vectors for Direct Gene Transfer into Adult Mouse Skeletal Muscle
Davis, H. L., Demeneix, B. A., Quantin, B., Coulombe, J., & Whalen, R. G. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.6-733 · Cited by 307
Intervening sequences increase efficiency of RNA 3' processing and accumulation of cytoplasmic RNA
Huang, M. T. F., & Gorman, C. M. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.4.937 · Cited by 303
Dai, Y., Roman, M., Naviaux, R. K., & Verma, I. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10892 · Cited by 302
How RNA polymerase II terminates transcription in higher eukaryotes
Proudfoot, N. J. (1989) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(89)90132-1 · Cited by 299
Promoter-regulatory region of the major immediate early gene of human cytomegalovirus.
Thomsen, D. R., Stenberg, R. M., Goins, W. F., & Stinski, M. F. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.3.659 · Cited by 296
Chapman, B. S., Thayer, R. M., Vincent, K. A., & Haigwood, N. L. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.14.3979 · Cited by 295
Definition of an efficient synthetic poly(A) site.
Levitt, N., Briggs, D., Gil, A., & Proudfoot, N. J. (1989) · Genes & Development · doi:10.1101/gad.3.7.1019 · Cited by 290
Protection against mycoplasma infection using expression-library immunization
Barry, M. A., Lai, W. C., & Albert Johnston, S. (1995) · Nature · doi:10.1038/377632a0 · Cited by 290
Direct Gene Transfer into Nonhuman Primate Myofibers In Vivo
Jiao, S., Williams, P., Berg, R. K., Hodgeman, B. A., Liu, L., Repetto, G., & Wolff, J. A. (1992) · Human Gene Therapy · doi:10.1089/hum.1992.3.1-21 · Cited by 283
MONTGOMERY, D. L., SHIVER, J. W., LEANDER, K. R., PERRY, H. C., FRIEDMAN, A., MARTINEZ, D., ULMER, J. B., DONNELLY, J. J., & LIU, M. A. (1993) · DNA and Cell Biology · doi:10.1089/dna.1993.12.777 · Cited by 262
Hohlfeld, R., & Engel, A. G. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90006-x · Cited by 254
Exposing the immunology of naked DNA vaccines
Pardoll, D. M., & Beckerleg, A. M. (1995) · Immunity · doi:10.1016/1074-7613(95)90085-3 · Cited by 249
Gene Expression Following Direct Injection of DNA into Liver
Hickman, M. A., Malone, R. W., Lehmann-Bruinsma, K., Sih, T. R., Knoell, D., Szoka, F. C., Walzem, R., Carlson, D. M., & Powell, J. S. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.12-1477 · Cited by 245
Bureau, T. E., & Wessler, S. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1411 · Cited by 244
Cancer Gene Therapy Using Plasmid DNA: Purification of DNA for Human Clinical Trials
Horn, N. A., Meek, J. A., Budahazi, G., & Marquet, M. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.5-565 · Cited by 243
Self-citationGil, A., & Proudfoot, N. J. (1987) · Cell · doi:10.1016/0092-8674(87)90292-3 · Cited by 221
Cancer Gene Therapy Using Plasmid DNA: Pharmacokinetic Study of DNA Following Injection in Mice
Lew, D., Parker, S. E., Latimer, T., Abai, A. M., Kuwahara-Rundell, A., Doh, S. G., Yang, Z.-Y., Laface, D., Gromkowski, S. H., Nabel, G. J., et al. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.5-553 · Cited by 208
Self-citationWolff, J. A., Dowty, M. E., Jiao, S., Repetto, G., Berg, R. K., Ludtke, J. J., Williams, P., & Slautterback, D. B. (1992) · Journal of Cell Science · doi:10.1242/jcs.103.4.1249 · Cited by 204
Keller, G. A., Scallen, T. J., Clarke, D., Maher, P. A., Krisans, S. K., & Singer, S. J. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.4.1353 · Cited by 190
Xu, D., & Liew, F. Y. (1995) · PubMed Central · Cited by 173
Systemic immunological effects of cytokine genes injected into skeletal muscle.
Raz, E., Watanabe, A., Baird, S. M., Eisenberg, R. A., Parr, T. B., Lotz, M., Kipps, T. J., & Carson, D. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4523 · Cited by 168
Harms, J. S., & Splitter, G. A. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.10-1291 · Cited by 161
Strong expression of foreign genes following direct injection into fish muscle
Hansen, E. E. T., Fernandes, K., Goldspink, G., Butterworth, P. H. W., Umeda, P. K., & Chang, K. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)81229-2 · Cited by 131
Gaffney, D., McLauchlan, J., Whitton, J. L., & Clements, J. B. (1985) · Nucleic Acids Research · doi:10.1093/nar/13.21.7847 · Cited by 124
Ghazal, P., Luboń, H., Fleckenstein, B., & Hennighausen, L. G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.11.3658 · Cited by 118
A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity.
Conry, R. M., LoBuglio, A. F., Loechel, F., Moore, S. E., Sumerel, L. A., Barlow, D. L., & Curiel, D. T. (1995) · PubMed · Cited by 118
Huang, M. T. F., & Gorman, C. M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.4.1805 · Cited by 109
Cancer Gene Therapy Using Plasmid DNA: Safety Evaluation in Rodents and Non-Human Primates
Parker, S. E., Vahlsing, H. L., Serfilippi, L. M., Franklin, C. L., Doh, S. G., Gromkowski, S. H., Lew, D., Manthorpe, M., & Norman, J. A. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.5-575 · Cited by 109
Self-citationGoodwin, E. C., & ROTTMAN, F. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42005-4 · Cited by 90
Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs.
Axelrod, J. H., Read, M. S., Brinkhous, K. M., & Verma, I. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5173 · Cited by 88
Muscle Delivery of Human Kallikrein Gene Reduces Blood Pressure in Hypertensive Rats
Xiong, W., Chao, J., & Chao, L. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.715 · Cited by 71
Immunity to MHC class I antigen after direct DNA transfer into skeletal muscle.
Geissler, E. K., Wang, J., Fechner, J. H., Burlingham, W. J., & Knechtle, S. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.2.413 · Cited by 60
Novel, high expressing and antibiotic-controlled plasmid vectors designed for use in gene therapy.
Liang, X., Hartikka, J., Sukhu, L., et al. (1996) · PubMed · Cited by 49
Self-citationMa, J.-X., Yang, Z., Chao, J., & Chao, L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.1.451 · Cited by 46
Direct gene transfer into mouse diaphragm
Davis, H. L., & Jasmin, B. J. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80393-9 · Cited by 38
Mantegazza, R., & Bernasconi, P. (1994) · Current Opinion in Rheumatology · doi:10.1097/00002281-199411000-00004 · Cited by 35
Toward clinical trials of DNA vaccines against malaria
Hoffman, S. L., Doolan, D. L., Sedegah, M., Wang, R., Scheller, L. F., Kumar, A. A., Weiss, W. R., Le, T. P., Klinman, D. M., Hobart, P. M., et al. (1997) · Immunology and Cell Biology · doi:10.1038/icb.1997.59 · Cited by 31
Self-citationWilliams, S. (1990) · Science · doi:10.1126/science.247.4947.1179 · Cited by 24
Cited by
Baumgartner, I., Pieczek, A., Manor, O., Blair, R., Kearney, M., Walsh, K., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.97.12.1114 · Cited by 1,098
DNA vaccines: ready for prime time?
Kutzler, M. A., & Weiner, D. B. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2432 · Cited by 1,077
“It remains to be seen whether modifications to the polyadenylation and termination signals influence gene expression, although early reports are promisin”
BackgroundChen, Z.-Y., He, C.-Y., Ehrhardt, A., & Kay, M. A. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00168-0 · Cited by 462
Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation
Rizzuto, G., Cappelletti, M., Maione, D., Savino, R., Lazzaro, D., Costa, P., Mathiesen, I., Cortese, R., Ciliberto, G., Laufer, R., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6417 · Cited by 325
Isner, J. M. (2002) · Nature · doi:10.1038/415234a · Cited by 309
Metadata
- Authors
- Hartikka, J., Sawdey, M., Cornefert-Jensen, F., Margalith, M., Barnhart, K., Nolasco, M., Vahlsing, H. L., Meek, J., Marquet, M., Hobart, P., Norman, J., & Manthorpe, M.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 1996-07
- Volume
- 7
- Issue
- 10
- Pages
- 1205-1217
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W2031598154
- Cited by
- 328
- References
- 51
- FWCI
- 9.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.